Patrick J. van Gorp

3.2k total citations
42 papers, 2.6k citations indexed

About

Patrick J. van Gorp is a scholar working on Epidemiology, Molecular Biology and Surgery. According to data from OpenAlex, Patrick J. van Gorp has authored 42 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Epidemiology, 18 papers in Molecular Biology and 15 papers in Surgery. Recurrent topics in Patrick J. van Gorp's work include Liver Disease Diagnosis and Treatment (18 papers), Cholesterol and Lipid Metabolism (10 papers) and Lipid metabolism and disorders (8 papers). Patrick J. van Gorp is often cited by papers focused on Liver Disease Diagnosis and Treatment (18 papers), Cholesterol and Lipid Metabolism (10 papers) and Lipid metabolism and disorders (8 papers). Patrick J. van Gorp collaborates with scholars based in Netherlands, Germany and United States. Patrick J. van Gorp's co-authors include Marten H. Hofker, Ronit Shiri‐Sverdlov, Marion J. Gijbels, Kristiaan Wouters, Veerle Bieghs, Dieter Lütjohann, Marc van Bilsen, Bart Staels, Tim Hendrikx and Louis M. Havekes and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Gastroenterology.

In The Last Decade

Patrick J. van Gorp

42 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Patrick J. van Gorp Netherlands	27	1.2k	880	707	550	517	42	2.6k
Hae‐Ki Min United States	21	1.7k 1.4×	1.2k 1.3×	461 0.7×	642 1.2×	401 0.8×	33	3.0k
Christopher Savard United States	22	1.3k 1.0×	906 1.0×	615 0.9×	489 0.9×	263 0.5×	43	2.5k
Hirohide Ohnishi Japan	31	1.4k 1.1×	1.2k 1.4×	1.2k 1.7×	477 0.9×	488 0.9×	100	3.7k
Michiko Itoh Japan	22	1.4k 1.1×	670 0.8×	335 0.5×	419 0.8×	379 0.7×	34	2.5k
Bettina G. Papouchado United States	21	1.5k 1.2×	903 1.0×	315 0.4×	408 0.7×	224 0.4×	28	2.4k
Antoni Paul United States	25	702 0.6×	717 0.8×	657 0.9×	253 0.5×	480 0.9×	48	2.5k
Atsushi Umemura Japan	27	1.9k 1.5×	1.6k 1.9×	557 0.8×	606 1.1×	463 0.9×	80	3.8k
Marica Meroni Italy	28	1.6k 1.3×	670 0.8×	400 0.6×	652 1.2×	161 0.3×	68	2.5k
Kouichi Miura Japan	25	2.2k 1.8×	1.3k 1.5×	535 0.8×	536 1.0×	452 0.9×	78	3.7k
Jennifer Altomonte Germany	26	693 0.6×	1.8k 2.1×	876 1.2×	697 1.3×	271 0.5×	52	3.6k

Countries citing papers authored by Patrick J. van Gorp

Since Specialization

Citations

This map shows the geographic impact of Patrick J. van Gorp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick J. van Gorp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick J. van Gorp more than expected).

Fields of papers citing papers by Patrick J. van Gorp

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick J. van Gorp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick J. van Gorp. The network helps show where Patrick J. van Gorp may publish in the future.

Co-authorship network of co-authors of Patrick J. van Gorp

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick J. van Gorp. A scholar is included among the top collaborators of Patrick J. van Gorp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick J. van Gorp. Patrick J. van Gorp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Houben, Tom, Yvonne Oligschlaeger, Tim Hendrikx, et al.. (2017). Cathepsin D regulates lipid metabolism in murine steatohepatitis. Scientific Reports. 7(1). 3494–3494. 48 indexed citations

Li, Jieyi, Dipanjan Chanda, Patrick J. van Gorp, et al.. (2016). Macrophage Stimulating Protein Enhances Hepatic Inflammation in a NASH Model. PLoS ONE. 11(9). e0163843–e0163843. 15 indexed citations

Jeurissen, Mike L. J., Sofie M. A. Walenbergh, Tom Houben, et al.. (2016). Myeloid DLL4 Does Not Contribute to the Pathogenesis of Non-Alcoholic Steatohepatitis in Ldlr-/- Mice. PLoS ONE. 11(11). e0167199–e0167199. 4 indexed citations

Walenbergh, Sofie M. A., Tom Houben, Tim Hendrikx, et al.. (2015). Plasma Cathepsin D Levels: A Novel Tool to Predict Pediatric Hepatic Inflammation. The American Journal of Gastroenterology. 110(3). 462–470. 37 indexed citations

Plat, Jogchum, Tim Hendrikx, Veerle Bieghs, et al.. (2014). Protective Role of Plant Sterol and Stanol Esters in Liver Inflammation: Insights from Mice and Humans. PLoS ONE. 9(10). e110758–e110758. 43 indexed citations

Hendrikx, Tim, Veerle Bieghs, Sofie M. A. Walenbergh, et al.. (2013). Macrophage Specific Caspase-1/11 Deficiency Protects against Cholesterol Crystallization and Hepatic Inflammation in Hyperlipidemic Mice. PLoS ONE. 8(12). e78792–e78792. 30 indexed citations

Walenbergh, Sofie M. A., Veerle Bieghs, Tim Hendrikx, et al.. (2012). 27-Hydroxycholesterol: a potential treatment for non-alcoholic steatohepatitis in mice. Data Archiving and Networked Services (DANS). 1 indexed citations

Bieghs, Veerle, Patrick J. van Gorp, Kristiaan Wouters, et al.. (2012). LDL Receptor Knock-Out Mice Are a Physiological Model Particularly Vulnerable to Study the Onset of Inflammation in Non-Alcoholic Fatty Liver Disease. PLoS ONE. 7(1). e30668–e30668. 126 indexed citations

Bieghs, Veerle, Patrick J. van Gorp, Sofie M. A. Walenbergh, et al.. (2012). Specific immunization strategies against oxidized low-density lipoprotein: A novel way to reduce nonalcoholic steatohepatitis in mice. Hepatology. 56(3). 894–903. 81 indexed citations

10.

Bieghs, Veerle, Tim Hendrikx, Patrick J. van Gorp, et al.. (2012). The Cholesterol Derivative 27-Hydroxycholesterol Reduces Steatohepatitis in Mice. Gastroenterology. 144(1). 167–178.e1. 76 indexed citations

11.

Wouters, Kristiaan, Marc van Bilsen, Patrick J. van Gorp, et al.. (2010). Intrahepatic cholesterol influences progression, inhibition and reversal of non‐alcoholic steatohepatitis in hyperlipidemic mice. FEBS Letters. 584(5). 1001–1005. 86 indexed citations

12.

Bieghs, Veerle, Patrick J. van Gorp, Marion J. Gijbels, et al.. (2010). Chorioamnionitis Induced Hepatic Inflammation and Disturbed Lipid Metabolism in Fetal Sheep. Pediatric Research. 68(6). 466–472. 24 indexed citations

13.

Vliet‐Ostaptchouk, Jana V. van, N. Charlotte Onland‐Moret, Ronit Shiri‐Sverdlov, et al.. (2008). Polymorphisms of the TUB Gene Are Associated with Body Composition and Eating Behavior in Middle-Aged Women. PLoS ONE. 3(1). e1405–e1405. 21 indexed citations

14.

Wouters, Kristiaan, Patrick J. van Gorp, Veerle Bieghs, et al.. (2008). Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis†. Hepatology. 48(2). 474–486. 391 indexed citations

15.

Schröder, Katrin, Carmine Vecchione, Oliver Jung, et al.. (2006). Xanthine oxidase inhibitor tungsten prevents the development of atherosclerosis in ApoE knockout mice fed a Western-type diet. Free Radical Biology and Medicine. 41(9). 1353–1360. 68 indexed citations

16.

Wouters, Kristiaan, Ronit Shiri‐Sverdlov, Patrick J. van Gorp, Marc van Bilsen, & Marten H. Hofker. (2005). Understanding hyperlipidemia and atherosclerosis: lessons from genetically modified apoe and ldlr mice. Clinical Chemistry and Laboratory Medicine (CCLM). 43(5). 470–9. 116 indexed citations

17.

Winther, Menno P.J. de, Marion J. Gijbels, Ko Willems van Dijk, et al.. (1999). Scavenger receptor deficiency leads to more complex atherosclerotic lesions in APOE3Leiden transgenic mice. Atherosclerosis. 144(2). 315–321. 82 indexed citations

18.

Jong, M.C.M. de, Marion J. Gijbels, Vivian E.H. Dahlmans, et al.. (1998). Hyperlipidemia and cutaneous abnormalities in transgenic mice overexpressing human apolipoprotein C1.. Journal of Clinical Investigation. 101(1). 145–152. 123 indexed citations

19.

Jong, M.C.M. de, Vivian E.H. Dahlmans, Patrick J. van Gorp, et al.. (1996). In the absence of the low density lipoprotein receptor, human apolipoprotein C1 overexpression in transgenic mice inhibits the hepatic uptake of very low density lipoproteins via a receptor-associated protein-sensitive pathway.. Journal of Clinical Investigation. 98(10). 2259–2267. 99 indexed citations

20.

Vlijmen, Bart J.M. van, Ko Willems van Dijk, Patrick J. van Gorp, et al.. (1996). In the Absence of Endogenous Mouse Apolipoprotein E, Apolipoprotein E*2(Arg-158 → Cys) Transgenic Mice Develop More Severe Hyperlipoproteinemia than Apolipoprotein E*3-Leiden Transgenic Mice. Journal of Biological Chemistry. 271(48). 30595–30602. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact